Cargando...

Intravitreal aflibercept for choroidal neovascularization secondary to angioid streaks in a non-responder to intravitreal ranibizumab

PURPOSE: To report the 12-month outcomes of a patient switching from intravitreal ranibizumab to aflibercept for choroidal neovascularization (CNV) associated with angioid streaks (AS). RESULTS: A 42-year-old Caucasian female with CNV associated with AS underwent intensive treatment with ranibizumab...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Int Med Case Rep J
Autores principales: Makri, Olga E, Tsapardoni, Foteini N, Plotas, Panagiotis, Pallikari, Athina, Georgakopoulos, Constantine D
Formato: Artigo
Lenguaje:Inglês
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6149836/
https://ncbi.nlm.nih.gov/pubmed/30271222
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IMCRJ.S166473
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!